CancerCare@CancerCare

CancerCare is a leading national organization dedicated to providing free support services and financial assistance to anyone affected by cancer. 800-813-HOPE

 New York, New York
cancercare.org/
Joined April 2009
3,324 Photos and videos
Last year, @CancerCare provided 150,508 services to people diagnosed with cancer, caregivers and bereaved individuals. Our emotional, practical and financial support programs continued to offer help and hope to anyone affected by cancer. Learn more at cancercare.org.
2
1
6
871
CancerCare retweeted
OncLive.com
@OncLive
Sep 24
🚨BREAKING @FDA News🚨 The FDA has approved belzutifan plus lenvatinib for the treatment of patients with advanced renal cell carcinoma with a clear cell component following treatment with PD-1 or PD-L1 inhibitor. Full details here ➡️: onclive.com/view/fda-approve… #kcsm #oncology
1
6
2,045
Today, the FDA approved a treatment for advanced renal cell carcinoma. fda.gov/drugs/resources-info…
4
12
47
8,400
FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma fda.gov/drugs/resources-info…

FDA approves lirafugratinib for previously treated, unresectable, loca

On September 23, 2026, the Food and Drug Administration approved lirafugratinib (Lyrfigtu, Elevar Therapeutics, Inc.), a kinase inhibitor, for the treatment of adults with previously treated unrese...

fda.gov
156
It’s here! Today is World ALL Day! On this day, we come together as a global community to raise awareness of acute lymphoblastic leukemia (ALL) and stand with every patient, caregiver & family affected. Join the global campaign: know-alleukemia.com/world-al… @_KNOW_ALL #KnowALL
1
1
204
Today, we approved a treatment for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. This approval gives some people with advanced breast cancer whose tumors have a specific genetic mutation another treatment option. fda.gov/drugs/resources-info…
4
21
41
7,647
CancerCare retweeted
Know ALL
@_KNOW_ALL
Aug 27
Save the date! Wednesday, September 30 | 16:00 (BST) Join the Know ALL patient webinar on Wednesday, September 30, for a conversation about personalized treatment, wellbeing, and support for older adults living with acute lymphoblastic leukemia. Register via the link in our comment below.
1
1
1
95
This #ThyroidCancerAwarenessMonth, hear how thyroid cancer (TC) survivor Becky and her husband, Michael, navigated the changes that came from her treatment and discovered a recipe they continue to enjoy today. Watch Becky’s story and try her recipe: bit.ly/4d1jIYc #ad
1
1
191
CancerCare retweeted
FDA Drugs and Biologics
@FDADrugs
Sep 9
Today, we granted accelerated approval to a treatment for locally advanced or metastatic non-squamous non-small cell lung cancer. fda.gov/drugs/resources-info…
A person in a blue shirt holds a white ribbon, symbolizing lung cancer awareness. Text on the image reads: "FDA grants accelerated approval to a treatment for non-small cell lung cancer." The FDA logo is visible in the corner.

ALT A person in a blue shirt holds a white ribbon, symbolizing lung cancer awareness. Text on the image reads: "FDA grants accelerated approval to a treatment for non-small cell lung cancer." The FDA logo is visible in the corner.

2
10
37
6,197
FDA grants accelerated approval to camizestrant with a CDK4/6 inhibitor for ESR1-Mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer fda.gov/drugs/resources-info…

FDA grants accelerated approval to camizestrant

On September 4, 2026, the Food and Drug Administration granted accelerated approval to camizestrant (Etcamah, AstraZeneca). Learn more.

fda.gov
1
235
If you are a head and neck cancer patient or caregiver, or know someone who may be interested in participating, we encourage you to complete and share the survey using the link below: loom.ly/goj17Ts
1
2
326
FDA approved daraxonrasib (RASONQUE, Revolution Medicines, Inc.), an inhibitor of the RAS GTPase family, for adults with metastatic pancreatic adenocarcinoma fda.gov/news-events/press-an…

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced...

fda.gov
1
197
Today we approved a first-in-class targeted therapy for metastatic pancreatic cancer – one of the hardest cancers to treat. Today’s approval provides a critical new treatment for patients who’ve had very few options. fda.gov/news-events/press-an…
14
85
260
52,194
Food and Drug Administration approved zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals) investor.jazzpharma.com/news…

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in...

Ziihera plus tislelizumab and chemotherapy approved for first-line treatment of all HER2+ GEA patients (IHC 3+ and IHC 2+/ISH+) regardless of PD-L1 status, establishing a new standard of care in...

investor.jazzpharma.com
311
NEWS: FDA approves a treatment for gastric, gastroesophageal junction, or esophageal adenocarcinoma. fda.gov/drugs/resources-info…
A person wearing a purple shirt with a purple ribbon pinned on it stands with arms crossed. The background features the FDA logo in the top right corner. Text on the image reads: "FDA approves a treatment for gastric, gastroesophageal junction, or esophageal adenocarcinoma.

ALT A person wearing a purple shirt with a purple ribbon pinned on it stands with arms crossed. The background features the FDA logo in the top right corner. Text on the image reads: "FDA approves a treatment for gastric, gastroesophageal junction, or esophageal adenocarcinoma.

3
13
27
5,817
CancerCare retweeted
OncLive.com
@OncLive
Aug 13
🚨BREAKING🚨: @FDA has granted accelerated approval to iberdomide plus daratumumab and hyaluronidase-fihj and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma. Read more here ➡️: onclive.com/view/fda-approve… #mmsm #oncology
3
11
17
2,115
CancerCare retweeted
NNJCF@NNJCF
Aug 7
#FeelGoodFriday 👨‍👩‍👧‍👦NNJCF announces its DeAnna Stark Pasciuto Memorial Fund awarded a grant of $5,000 to @CancerCare in Paramus. ▶Learn more about NNJCF's #donoradvisedfund services & how you can establish one or support an existing one: nnjcf.org/donor-services/est… #NNJCF #cancer
1
1
58
💬 "The most effective cancer treatment plan is not simply the one that is medically optimal—it's the one that a patient is realistically able to access, navigate and complete." - @CancerCare's Angelique Caba Read the full interview here >>> hubs.ly/Q04pk_Bb0

How do immigration-related fears shape cancer care and outcomes?

In our latest interview, Angelique Caba discusses how immigration-related fears directly influence treatment adherence and outcomes.

oncology-central.com
1
2
165
The Made of More mission reminds us that people affected by head and neck cancer (HNC) and thyroid cancer (TC) are so much more than their diagnosis. Explore stories from real survivors and caregivers that reflect resilience and strength: bit.ly/40aJmCu #ad
210
FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for melanoma fda.gov/drugs/resources-info…

FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in c

On August 6, 2026, the Food and Drug Administration granted accelerated approval to vusolimogene oderparepvec-wtpg (Tudriqev, Replimune, Inc.), a genetically modified oncolytic viral therapy, in...

fda.gov
258
Load more